Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Kelcher, 13 are a HOLD (68.42%), 5 are a BUY (26.32%), 1 are a SELL (5.26%).
Analyst Jonathan Kelcher, currently employed at TD COWEN, carries an average stock price target met ratio of 56.67% that have a potential upside of 17.08% achieved within 237 days. Previously, Jonathan Kelcher worked at TD SECURITIES.
Jonathan Kelcher’s has documented 33 price targets and ratings displayed on 6 stocks.
Most recent stock forecast was given on EXETF, Extendicare at 11-Mar-2024.
Analyst best performing recommendations are on EXETF (EXTENDICARE).
The best stock recommendation documented was for EXETF (EXTENDICARE) at 3/11/2024. The price target of $7.5 was fulfilled within 263 days with a profit of $2.37 (46.2%) receiving and performance score of 1.76.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$90.5
$0.14 (0.15%)
3 years 5 months 11 days ago
(22-Mar-2022)
3/4 (75%)
$0.74 (0.82%)
40
Hold
$90.5
$0.14 (0.15%)
$90
3 years 6 months 16 days ago
(17-Feb-2022)
14/15 (93.33%)
$1.14 (1.28%)
277
$90
3 years 7 months ago
(02-Feb-2022)
11/11 (100%)
$1.58 (1.79%)
209
Hold
$90
$-0.36 (-0.40%)
$90.5
3 years 7 months ago
(02-Feb-2022)
1/3 (33.33%)
$0.51 (0.57%)
51
Hold
$88
$-2.36 (-2.61%)
$88
3 years 9 months 4 days ago
(29-Nov-2021)
10/11 (90.91%)
$-0.35 (-0.40%)
220
What Year was the first public recommendation made by Jonathan Kelcher?